Ireland
--:--IST
Latest
Clinical Trials in France / NCT05949567
Recruiting Not applicable

Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population

NCT05949567 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-04-02
Last updated
2026-04-17

Condition(s) studied

Urodynamic ExamNeurologic Disorder

Investigational drug(s) / intervention(s)

urodynamic exam in sitting and lying position

urodynamic exam in sitting and lying position: Urodynamic exam with 1st filling in sitting or lying position. Then , during the same procedure, a second filling in the opposite position of the 1st filling (lying or sitting)

Study summary

ICS (International Continence Society) recommendations published in 2017 recommend performing urodynamic examinations in the sitting or standing position. These recommendations are based on a review of the literature published in 2008, which has several limitations: heterogeneous populations, old and non-harmonized techniques, and very few neurological patients. It seems appropriate to focus on neurological patients and to examine the influence of position on the detection of detrusor overactivity in these patients.

The point here is to reexamine the ICS recommendations, which are not designed for neurological patients. Indeed, many patients suffering from Multiple Sclerosis (MS) or Parkinson's disease are unable to sit or stand for the duration of the urodynamic examination. The investigators would like to assess whether exploring sphincter disorders in the supine position is still interpretable.

This would enable us to define ICS good practice recommendations for a neurological population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient with MS or neurologically confirmed Parkinson's disease, with indication for urodynamic assessment - 1st assessment * Clinical overactive bladder syndrome with USP overactive bladder sub-score \> or = 4 - Age ≥18 years * In men: no prostatic hypertrophy on ultrasonography * In women: no stress urinary incontinence (SUI); USP SUI subscore ≤ 2 * Affiliated with a social security scheme (excluding AME). * Free and informed written consent Exclusion Criteria: * Opposition to the performance of a Urodynamic exam as part of treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Physical and Rehabilitation Medicine Pitié Salpêtrière Hospital Paris France Recruiting

More Assistance Publique - Hôpitaux de Paris trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05949567 on ClinicalTrials.gov ↗ ← All trials in France